Ricolinostat: Additional Phase Ib data

Data from 25 patients with relapsed or refractory MM in the open-label, dose-escalation, U.S. Phase Ib ACE-MM-101 trial showed that oral ricolinostat plus Revlimid lenalidomide and dexamethasone led ...